Merck is spinning off products from the company’s Women’s Health, Legacy Brands and Biosimilars businesses.

Eton Pharmaceuticals Inc. submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration for the injectable hospital-use product candidate DS-200 via the Rolling Review process.

Pfizer Inc. announced that the company will organize into three businesses: Innovative Medicines, Established Medicines, and Consumer Healthcare.

U.S. hospital products maker Baxter International Inc. forecast a nearly $70 million hit to its fourth-quarter 2017 revenue, due to manufacturing disruptions arising from Hurricane Maria.